Clearside Biomedical (CLSD) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts CLSD Hot Sheet
Join SI Premium – FREE
Clearside Biomedical (NASDAQ: CLSD) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Saudi Arabia Oil Pipeline Struck By Projectiles Thursday - CNN
- DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
- CDC Says Cyclospora Outbreak Linked To Iceberg Lettuce Is Over
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
